Emergent Biosolutions EBS Return on equity

Return on equity at other companies

Thermo Fisher ScientificTMO

13.5%+0.1pp

Regeneron PharmaceuticalsREGN

14%-1.3pp

SIGA TechnologiesSIGA

39.9%-18.5pp

Amneal Pharmaceuticals, Inc.AMRX

-52.8%-12.7pp

Lifecore Biomedical, Inc.LFCR

-612.1%—

Rapid Micro BiosystemsRPID

-141.6%-501pp

FAQ

What is Emergent Biosolutions's return on equity?

Emergent Biosolutions (EBS) reported return on equity of 13.9% in Q3 2025.

How has Emergent Biosolutions's return on equity changed year-over-year?

Emergent Biosolutions's return on equity increased by 140.2% year-over-year, from -34.6% to 13.9%.

What is the long-term trend for Emergent Biosolutions's return on equity?

Over 4 years (2020 to 2024), Emergent Biosolutions's return on equity has grown at a 8.8% compound annual growth rate (CAGR), from 24% to -33.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.